Press Releases
Evans Heating & Cooling Provides Comprehensive AC Repair in Blythewood With a Focus on Restoring HVAC System Performance
Blythewood, SC - As seasonal temperature swings increase demand on residential heating and cooling systems, Evans Heating & Cooling continues to serve Blythewood homeowners with HVAC diagnostics, repairs, maintenance, and replacement services. The family-owned company combines 48 years of industry experience with NATE-certified, factory-trained technicians who service all major brands and provide emergency support for urgent heating and cooling problems.
Via GetFeatured · November 6, 2026
PCM Encore Announced As Sponsor Of The Benzinga Awards 2026
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via NewMediaWire · November 6, 2026
Hawkeye Digital Partners With Securitize to Tokenize Its Shares
Hawkeye Digital, Inc. (OTC: HWKE) (“Hawkeye” or the “Company”), a publicly traded private equity incubator and merchant banking platform, today announced a partnership with Securitize Corp. (NYSE: SECZ) to tokenize the Company’s common stock on Ethereum. The partnership will provide eligible shareholders a new way to own Hawkeye: real shares, held in digital form, on modern infrastructure.
By Hawkeye Digital, Inc. · Via Business Wire · November 6, 2026
IntouchCX Recognized for Operations led AI and End to End CX Transformation by HFS Research
IntouchCX a global leader in AI-powered customer experience (CX) management, trust and safety, digital engagement, and back-office operations, has been positioned in the Horizon 2 end-to-end experience transformation, in the HFS Horizons Customer Experience Services 2026 report for its operations led approach to AI adoption and its model connecting advisory with delivery, from strategy through frontline executions.
By IntouchCX · Via Business Wire · November 6, 2026
Tapstitch Examines Fashion Apparel Print-on-Demand Service Choices
United States of America, November 5th — Tapstitch presents a framework for comparing print-on-demand services for fashion apparel, focusing on how the garment, decoration, branding and fulfillment route work together. The framework considers Tapstitch, Printful, Printify and Apliiq against the same product requirements rather than naming a universal winner.
Via GlobePRwire · November 6, 2026
Insperity to Participate in the J.P. Morgan 2026 Ultimate Services Investor Conference
Insperity, Inc. (NYSE: NSP), a leading provider of human resources and business performance solutions for America’s best businesses, announced today that Paul Sarvadi, Chairman and Chief Executive Officer, and Jim Allison, Chief Financial Officer, will speak at the J.P. Morgan Ultimate Services Investor Conference on November 17, 2026. The fireside chat presentation is scheduled for 3:20 p.m. Eastern Time.
By Insperity, Inc. · Via Business Wire · November 6, 2026
Cancer Grand Challenges Researchers to Put AI Co-Scientists to the Test in Cancer Research
Cancer Grand Challenges today announced the first cohort of international teams selected to join AURORA, a pioneering project that aims to help scientists make faster progress against cancer’s toughest challenges using AI.
By Cancer Grand Challenges · Via Business Wire · November 6, 2026
The Estée Lauder Companies Unveils Mastering Skin Longevity, a Breakthrough Scientific Innovation Platform Advancing the Next Era of Skin Science
At the China International Import Expo (CIIE), The Estée Lauder Companies Inc. (NYSE: EL) today unveiled Mastering Skin Longevity, a breakthrough scientific innovation platform designed to advance the next era of skin science and transformative product innovation.
By The Estée Lauder Companies Inc. · Via Business Wire · November 6, 2026
Agenus Reports More Than Half of Patients with Refractory MSS Metastatic Colorectal Cancer Achieved Long-Term Survival Following BOT+BAL Treatment at SITC 2026
Agenus Inc. (Nasdaq: AGEN), a leader in immuno-oncology innovation, today announced new findings from a long-term survivor analysis of its Phase 1b C-800-01 trial evaluating botensilimab (BOT), a multifunctional, Fc-enhanced anti-CTLA-4 antibody, in combination with balstilimab (BAL), an anti-PD-1 antibody, in heavily pretreated patients with microsatellite-stable (MSS) metastatic colorectal cancer (mCRC) without active liver metastases. The results were presented in a poster by Thomas U. Marron, MD, PhD, of the Tisch Cancer Center at Mount Sinai, at the Society for Immunotherapy of Cancer (SITC) 2026 Annual Meeting in Phoenix, Arizona.
By Agenus Inc. · Via Business Wire · November 6, 2026
The Platform Opens in Kendall Square with BANDALOOP Performance
BioMed Realty, Global Arts Live and Takeda celebrated the grand opening of The Platform at 585 Kendall on Nov. 5, marking the arrival of a new performing arts center designed to expand access to professional performance, rehearsal and gathering space in Cambridge.
By BioMed Realty · Via Business Wire · November 6, 2026
Experian Named a Leader in 2026 IDC MarketScape for Worldwide Decision Intelligence Platforms
Experian today announced it has been named a Leader in the IDC MarketScape: Worldwide Decision Intelligence Platforms 2026 Vendor Assessment (Doc #US54118426, September 2026), which evaluates providers helping organizations design, engineer and orchestrate increasingly complex decisions.
By Experian · Via Business Wire · November 6, 2026
Owlet to Report Third Quarter 2026 Financial Results on November 13, 2026
Owlet, Inc. (“Owlet” or the “Company”) (NYSE: OWLT) plans to announce third quarter 2026 financial results before the market opens on Friday, November 13, 2026. Owlet’s President, Chief Executive Officer, and Co-Founder, Kurt Workman, and Chief Financial Officer, Amanda Twede Crawford, will host a conference call at 8:30 a.m. ET the same day to discuss these results and provide a business update.
By Owlet, Inc. · Via Business Wire · November 6, 2026
Starfighters Space Reschedules Investor Update to Nov. 20
Starfighters Space, Inc. ("Starfighters" or the "Company") (NYSE American: FJET), the space company operating the world's only commercial fleet of flight-ready Mach 2+ supersonic aircraft, must reschedule a live briefing by CEO Tim Franta from Nov. 6 to Nov. 20. A newly announced visit by senior government officials to the Company’s hangar at Kennedy Space Center on Nov. 6 will require Mr. Franta’s presence during the hours previously planned for the investor update. The government officials will provide a public announcement on aerospace policy during an event in the Company’s hangar.
By Starfighters Space, Inc. · Via Business Wire · November 6, 2026
Scale LLP Adds Telecom Team in DC, Expanding Media and Licensing Capabilities
Scale LLP, a full-service national law firm, is expanding its telecommunications and media capabilities with the addition of two new attorneys, Seth Williams and Adam Sandler. It follows the addition earlier this year of Allison Rule and Michael Donahue to Scale’s growing DC-based telecom practice.
By Scale LLP · Via Business Wire · November 6, 2026
Indapta Therapeutics Announces Oral Presentation of Clinical Proof-of-Concept Data for IDP-023 Allogeneic g-NK Cell Therapy Plus Isatuximab in Heavily Pretreated Multiple Myeloma at 2026 Annual Meeting of Society for Immunotherapy of Cancer
Indapta Therapeutics, Inc., a privately held clinical stage biotechnology company developing next-generation differentiated immunotherapies for the treatment of cancer and autoimmune diseases, today announced that complete Phase 1 data for IDP-023, the Company’s allogeneic g-NK cell therapy, in combination with isatuximab in patients with relapsed/refractory multiple myeloma (RRMM) will be featured in an oral presentation at the Society for Immunotherapy of Cancer (SITC) 41st Annual Meeting, taking place November 4–8, 2026, in Phoenix, Arizona.
By Indapta Therapeutics, Inc. · Via Business Wire · November 6, 2026
Did You Lose Money on Madrigal Pharmaceuticals, Inc. Stock? The Law Offices of Howard G. Smith Announces Securities Fraud Investigation After 8.1% Share Price Decline
Investors who suffered losses on Madrigal Pharmaceuticals, Inc. ("Madrigal" or the "Company") stock may have claims to recover those losses. The Law Offices of Howard G. Smith today reported that it is conducting a securities fraud investigation on behalf of Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL) investors into whether the Company may have violated the federal securities laws. The investigation comes after a November 3, 2026 disclosure concerning Madrigal Pharmaceuticals, Inc.
By The Law Offices of Howard G. Smith · Via Business Wire · November 6, 2026
PharmaEssentia to Present Additional BESREMi® Data Across Polycythemia Vera and Essential Thrombocythemia at ASH 2026
PharmaEssentia USA Corporation, a subsidiary of PharmaEssentia Corporation (TWSE: 6446) today announced it will be presenting one oral presentation, nine posters, and five online publications at the 68th American Society of Hematology (ASH) Annual Meeting, taking place December 12-15 in New Orleans, Louisiana.
By PharmaEssentia USA Corporation · Via Business Wire · November 6, 2026
Aimbridge Hospitality Selected to Manage Seattle Marriott Redmond
Aimbridge Hospitality has been selected to manage the Seattle Marriott Redmond. The company will assume management of the hotel in January 2027.
By Aimbridge Hospitality · Via Business Wire · November 6, 2026
Did You Lose Money on Dave, Inc. Stock? The Law Offices of Howard G. Smith Announces Securities Fraud Investigation After 18.11% Share Price Decline
Investors who suffered losses on Dave, Inc. ("Dave" or the "Company") stock may have claims to recover those losses. The Law Offices of Howard G. Smith today reported that it is conducting a securities fraud investigation on behalf of Dave, Inc. (NASDAQ: DAVE) investors into whether the Company may have violated the federal securities laws. The investigation comes after a November 4, 2026 disclosure concerning Dave, Inc.
By The Law Offices of Howard G. Smith · Via Business Wire · November 6, 2026
Stagwell Media Names Kate Richling as Chief Brand and Communications Officer
As marketers seek agile media partners, Richling, former Monks Global CMO, joins Stagwell Media to drive global brand strategy and elevate a technology-led growth narrative.
By Stagwell · Via ACCESS Newswire · November 6, 2026
pixiv Announces 2026 Christmas Charity Partnership With Book Santa, a Social Welfare Project Providing Books to Children
For every Christmas- or Book-themed Novel or Essay Submitted, pixiv will Donate 500 JPY!
By pixiv Inc. · Via ACCESS Newswire · November 6, 2026
Sterling Brokers Acquires Lucite, Bringing AI and Enterprise-Grade Tools to Canada’s Independent Benefits Brokers
Sterling Brokers, a Canadian employee benefits brokerage, today announced its acquisition of Lucite, an AI platform that helps benefits brokers analyze data, automate workflows and deliver improved service to clients. The acquisition expands Sterling’s reach beyond its own brokerage, bringing technology and administration services to independent brokers across Canada.
By Sterling Brokers · Via Business Wire · November 6, 2026
Did You Lose Money on MNTN, Inc. Stock? The Law Offices of Howard G. Smith Announces Securities Fraud Investigation After 54.68% Share Price Decline
Investors who suffered losses on MNTN, Inc. ("MNTN" or the "Company") stock may have claims to recover those losses. The Law Offices of Howard G. Smith today reported that it is conducting a securities fraud investigation on behalf of MNTN, Inc. (NYSE: MNTN) investors into whether the Company may have violated the federal securities laws. The investigation comes after a November 4, 2026 disclosure concerning MNTN, Inc.
By The Law Offices of Howard G. Smith · Via Business Wire · November 6, 2026
Onchilles Pharma Reports First Clinical Data at SITC 2026 That N17350 Could Turn One Tumor into a Personalized Cancer Vaccine
Onchilles Pharma, a clinical-stage biotechnology company pioneering next-generation cancer therapeutics that harness the ELANE pathway, today announced preliminary clinical findings from OP-NEU-101, its Phase 1/2 trial of intratumoral N17350 in patients with advanced solid tumors. Derived from a cancer-killing enzyme present in human neutrophils, N17350 is designed to use the injected tumor as a source of antigens that may help train the immune system to attack cancer elsewhere in the body without the need for tumor sequencing, antigen selection, or custom manufacturing. The findings provide an early clinical test of this approach and will be presented at the 41st Annual Meeting of the Society for Immunotherapy of Cancer (SITC).
By Onchilles Pharma · Via Business Wire · November 6, 2026
lululemon Introduces the Ventscape™ Run Vest – A Product Innovation that Simplifies Cold-Weather Running
lululemon (NASDAQ: LULU) today unveiled the Ventscape™ PrimaLoft® ThermoPlume®+ Run Vest, a new product innovation for cold-weather running, during the 2026 China International Import Expo.
By lululemon athletica inc. · Via Business Wire · November 6, 2026
Donaldson Company to Present at the Baird 2026 Global Industrial Conference
Donaldson Company, Inc. (NYSE: DCI), a leading worldwide provider of innovative filtration products and solutions, today announced Rich Lewis, president and chief executive officer, will present at the Baird 2026 Global Industrial Conference in Chicago, Illinois on Wednesday, November 11, beginning at 2:20 p.m. CT.
By Donaldson Company, Inc. · Via Business Wire · November 6, 2026
Immunocore reports third quarter financial results and provides a business update
KIMMTRAK® (tebentafusp-tebn) net revenues of $102.2 million in Q3 2026 and net revenues of $324.8 million for the first nine months of 2026, representing 10% year-over-year growth year to date
By Immunocore Holdings plc · Via GlobeNewswire · November 6, 2026
Azalea Therapeutics Presents New Preclinical Data at SITC 2026 Highlighting Durable Anti-Tumor Activity and Modular Capabilities of its In Vivo CAR T Cell Platform
BERKELEY, Calif., Nov. 06, 2026 (GLOBE NEWSWIRE) -- Azalea Therapeutics, Inc., a biotechnology company redefining precision genomic medicines in vivo, today announced new preclinical data demonstrating durable anti-tumor activity and the versatility of its proprietary in vivo TRAC-CAR T cell platform. The findings, to be presented at the Society for Immunotherapy of Cancer 41st Annual Meeting (SITC 2026), taking place November 4 – 8, 2026, in Phoenix, Arizona, highlight the platform’s ability to generate functional CAR T cells through precise genomic integration, achieve durable tumor control across hematologic and solid tumor models and enable advanced engineering strategies designed to address key limitations of conventional CAR T cell therapies.
By Azalea Therapeutics · Via GlobeNewswire · November 6, 2026
Dual-Channel Isolated Gate Drivers from Diodes Incorporated Enable Flexible, Reliable Half-Bridge and Independent Gate-Drive Topologies for Switching Applications
Diodes Incorporated (Diodes) (Nasdaq: DIOD) today announces the release of the API21550/API21552 series within its RobustISO™ family of isolation products. These dual-channel isolated gate drivers are designed for system engineers who require robust, high-voltage isolation and reliable signal transmission for power-switch driving. Applications include motor drives, solar inverters, battery management systems (BMS), servers, IT and industrial infrastructures, and high-voltage DC-DC converters.
By Diodes Incorporated (P) · Via Business Wire · November 6, 2026
Afognak Native Corporation announces Autumn Sellars as Interim CEO
ANCHORAGE, Alaska, Nov. 06, 2026 (GLOBE NEWSWIRE) -- Afognak Native Corporation announces the appointment of Autumn Sellars as its Interim CEO effective November 5, 2026. Sellars joined Alutiiq, LLC, a wholly owned subsidiary of Afognak, in 2017 when Alutiiq acquired her company Alcyon, Inc. Prior to her appointment as Interim CEO, Sellars served as Alutiiq’s Operations & Compliance Executive.
By Afognak Native Corporation · Via GlobeNewswire · November 6, 2026
Remitly Announces Upcoming Webinar and Investor Conference Participation
SEATTLE, Nov. 06, 2026 (GLOBE NEWSWIRE) -- Remitly Global, Inc. (NASDAQ: RELY) (“Remitly”), a trusted provider of financial services that transcend borders, today announced that its management team will present at the following investor conferences:
By Remitly, Inc. · Via GlobeNewswire · November 6, 2026
NaphCare Charitable Foundation CEO William Jett, Ph.D., Named A Birmingham Business Journal CEO Awards Honoree
NaphCare, a leader in correctional healthcare, and the NaphCare Charitable Foundation announced that William Jett, Ph.D., Chief Executive Officer, has been named a 2026 Birmingham Business Journal CEO Awards honoree. The recognition highlights his leadership in advancing healthcare research, developing emerging talent, and applying technology to challenges affecting underserved populations.
By NaphCare · Via Business Wire · November 6, 2026
Atebimetinib Combinations with Anti-PD1 Cured 50% of Mice in a RAS-Mutant Colorectal Cancer Model and Nearly Doubled Survival in a RAS-Mutant Lung Cancer Model; New Data Presented at SITC 2026
- Durable complete regressions observed in 50% of mice in a RAS-mutant colorectal cancer model treated with Atebimetinib plus anti-PD-1, with no regrowth even after dosing stopped -
By Immuneering Corporation · Via GlobeNewswire · November 6, 2026
Getty Images Confirms Release of Third Quarter 2026 Financial Results on November 16
NEW YORK, Nov. 06, 2026 (GLOBE NEWSWIRE) -- Getty Images Holdings, Inc. (“Getty Images”) (OTC Pink: GETYQ), the preeminent source of authentic visual content and coverage, confirmed that it will release third quarter 2026 financial results after market close on Monday, November 16, 2026, as scheduled. It will not hold a conference call and webcast in light of the Company's Chapter 11 restructuring process.
By Getty Images, Inc. · Via GlobeNewswire · November 6, 2026
Candel Therapeutics Presents SITC 2026 Data Highlighting Systemic Immune Activation and Survival Outcomes Across Clinical-Stage Portfolio
Three posters, including a late-breaking presentation, provide new clinical and biomarker data for aglatimagene besadenovec (aglatimagene) in localized prostate cancer and non-small cell lung cancer (NSCLC), and for linoserpaturev in recurrent glioblastoma
By Candel Therapeutics · Via GlobeNewswire · November 6, 2026
DAN GREANEY USA: Simpsons writer Dan Greaney Brings Presidential Campaign Tour to Springfield, USA November 5–24
The longtime Simpsons writer and progressive Republican presidential candidate will visit Springfields across America to explore shared concerns
By Dan Greaney USA · Via GlobeNewswire · November 6, 2026
Green River Throws a Flag on Game-Day Bullsh!t With a $20 Refund for Fans
Fans signed up to support their teams. Somewhere along the way, tailgating and game day got ridiculous. Overpriced parking. Concession-stand sticker shock. A souvenir hat that costs more than the outfit worn to the game. Green River, the Bourbon Without the Bullsh!t, is throwing a flag.
By Green River · Via Business Wire · November 6, 2026
ACE Survey Finds 35% of Adults Wouldn't Have Returned to School Without Online Options
Flexibility is a key factor for adults re-enrolling for graduate or certification programs.
By American College of Education · Via ACCESS Newswire · November 6, 2026
Surf Air Mobility Reports Third Quarter 2026 Financial Results, Meeting Revenue and Adjusted EBITDA Guidance
November 6, 2026
Via PressReach · November 6, 2026
Mav Gallery & Palm Beach Hedge Fund Association Present an Exclusive Miami Art Week Evening
Where contemporary art, real estate investment, and inspired spaces come together
Via Newsfile · November 6, 2026
APA Applauds Medicare Payment Increases for Collaborative Care
2027 payment changes advanced by APA advocacy strengthen mental health treatment in primary care through psychiatrists’ medical expertise
By American Psychiatric Association · Via GlobeNewswire · November 6, 2026
SMX: Plastic Recycling is no Longer a Favor; it's a Must
NEW YORK CITY, NY / ACCESS Newswire / November 6, 2026 / The economics of plastic have turned recycling from an act of corporate responsibility into a financial imperative. SMX sits at the center of that shift, providing the authentication and traceability technology that allows recycled plastic to function as a trusted industrial material. With war, volatile oil prices, inflation, supply-chain pressures, higher diesel and transportation costs, tariffs and the threat of plastic taxes driving up the expense of virgin production, using recycled material is increasingly about protecting margins and controlling costs, not simply protecting the planet.
By SMX (Security Matters) Public Limited · Via ACCESS Newswire · November 6, 2026
Fifth Annual Unplugged & Uncorked Marks Historic Fundraising Night for Musicians On Call
Sold-out philanthropic celebration at New York City’s Ziegfeld Ballroom featured exceptional wines, exclusive experiences, and fundraising in support of the healing power of music
By Musicians On Call · Via GlobeNewswire · November 6, 2026
Oil & Gas Virtual Investor Conference Presentations Now Available On Demand
Individual and institutional investors, advisors and analysts can now view presentations online
By Virtual Investor Conferences · Via GlobeNewswire · November 6, 2026
Lotus Tech to Present at the dbVIC - Deutsche Bank ADR Virtual Investor Conference November 12th
Company invites individual and institutional investors, as well as advisors and analysts, to attend online at VirtualInvestorConferences.com
By Virtual Investor Conferences · Via GlobeNewswire · November 6, 2026
Vontier Declares Regular Dividend
Vontier Corporation (“Vontier”) (NYSE: VNT), a leading global provider of critical technologies and solutions to connect, manage and scale the mobility ecosystem, announced today that its Board of Directors declared a regular quarterly cash dividend of $0.025 per share payable on December 10, 2026 to stockholders of record on November 19, 2026. Although Vontier expects to pay dividends on a quarterly basis, any subsequent declaration of dividends, including the amount, the record dates and the payment dates for any such future dividend payments, is subject to the discretion of the Board of Directors.
By Vontier Corporation · Via Business Wire · November 6, 2026
BostonGene Showcases Biologically Grounded AI at ACR Convergence 2026 to Advance Precision Rheumatology and Autoimmune Disease Stratification
BostonGene, developer of an AI model for tumor and immune biology, announced today that it will present new data demonstrating the application of its biologically grounded AI in non-oncology indications at the American College of Rheumatology (ACR) Convergence 2026. ACR Convergence 2026, the world's premier rheumatology event, will be held November 6–11 at the Orange County Convention Center in Orlando, Florida.
By BostonGene · Via Business Wire · November 6, 2026
AI Search Optimization Powered by Rank Intelligence Engine: Services Announced
AI Search Engine Optimization announces its AI SEO services, combining proprietary ranking intelligence, hands-on WordPress improvements, and performance tracking to help businesses compete in Google and AI-powered search.
Via Press Release Distribution Service · November 6, 2026
Gogo Completes Amendment and Extension of ~$600 Million Term Loan B Deleveraging Transaction
Reaffirms Company’s commitment to strengthening its financial position through deleveraging
By Gogo · Via GlobeNewswire · November 6, 2026
FCC Renews Gogo’s Air-to-Ground Spectrum Licenses Through 2036
10-year renewal secures Gogo’s exclusive nationwide 800 MHz ATG spectrum, the foundation of its North American business aviation network
By Gogo · Via GlobeNewswire · November 6, 2026
